Patients must have a histologically-proven diagnosis of atypical meningioma or a clinical diagnosis of an unresectable meningioma.
Patients must have radiographic proof of tumor progression and/or tumor recurrence, despite conventional treatment, including surgery, radiosurgery and/or external beam radiation therapy. Patients may also have had chemotherapy.